Table 1 Baseline characteristics
Female (% of participants) | T2DM (% of participants) | T2DM duration, years (median ± SD) | HT (% of participants) | Dyslipidemia (% of participants) | OSA (% of participants) | Arthrosis (% of participants) | |
|---|---|---|---|---|---|---|---|
RYGB (n = 30) | 20 | 13 | 3.0 ± 5.9) | 18 | 8 | 12 | 16 |
OAGB (n = 30) | 21 | 11 | 7.0 ± 4.9) | 16 | 8 | 12 | 15 |